INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma Meeting Abstract
| Authors: | Blumenthal, D.; Mellinghoff, I. K.; van den Bent, M. J.; Touat, M.; Peters, K.; Clarke, J.; Mendez, J.; Welsh, L.; Mason, W.; Hottinger, A. F.; Sanchez, J. M. S.; Wick, W.; Soffietti, R.; Tron, A.; Zhao, D.; Pandya, S.; Steelman, L.; Hassan, I.; Wen, P.; Cloughesy, T. |
| Abstract Title: | INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S391 |
| Language: | English |
| ACCESSION: | WOS:001087480200485 |
| DOI: | 10.1016/j.annonc.2023.09.1692 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 498O-- Source: Wos |
